Interestingly, myelin-reactive T cells – present in MS patients and healthy donors with comparable frequencies – have been determined by single-cell cloning to produce more IFN-γ, IL-17, and GM-CSF and less IL-10 in MS patients compared to healthy controls (10). This evidence concerns the gene CSF2 and myeloid sarcoma.